It prompted us to explore this relationship and think outside the box, so to speak. Researchers used propensity scores to match the two groups with each other based on several factors in a 1:1 ratio: current age, age at index event (time of medication prescription), sex, race, ethnicity, history of COPD, asthma, diabetic or other gastroparesis, chronic bronchitis, GERD, GERD-related cough, chronic rhinitis, postnasal drip, heart failure, tobacco use, overweight status, obesity status, metformin use, insulin use, and use of a common angiotensin-converting enzyme inhibitor. The group with type 2 diabetes plus a GLP-1RA prescription (liraglutide, semaglutide, exenatide, dulaglutide or lixisenatide) was made up of 427,555 adults (mean age, 55.8 years
Always use pharmacies licensed in your state
These effects are typically most pronounced during dose escalation and tend to diminish over time as the body adapts to the medication
Perhaps we should really find the real root cause
It also includes guidance for holding doses during acute illness